10步法机器人根治性子宫切除术治疗宫颈腺癌术前近距离放疗后
本文通过手术视频展示了一位48岁IB2期宫颈腺癌(肿瘤27mm)患者在接受术前脉冲剂量率子宫阴道近距离放疗后,按10个可重复步骤进行的机器人根治性子宫切除术。该标准化方法参考了ARCAGY研究组外科医生组的近期建议,强调阴道途径切开阴道、避免使用举宫器,并彻底机器人辅助缝合阴道残端。目前尚无国际推荐的根治性子宫切除术式,需告知患者不同手术路径的风险获益比。
要点
- 机器人根治性子宫切除术可按10个标准化步骤实施,包括盆腔前哨淋巴结识别和阴道途径阴道切开。
- 阴道切开应在完全气腹放气后经阴道途径进行,并严格避免使用举宫器。
- 术前近距离放疗在经验丰富的中心可使约70%患者达到病理完全缓解,尤其适用于肿瘤2-4cm或有淋巴血管浸润者。
核心结论
- 目前尚无国际推荐的根治性子宫切除术式,患者需明确知晓不同手术路径的风险获益比。
- 若决定行微创根治性子宫切除术,患者应转诊至经验丰富的中心并采取预防措施。
研究设计与样本
- 手术视频逐步演示技术,设置于妇科肿瘤和微创手术的三级中心。
- 患者为48岁女性,诊断为IB2期宫颈内膜腺癌(FIGO 2018),肿瘤大小27mm。
主要发现
- 手术在术前脉冲剂量率子宫阴道近距离放疗后按10个可重复步骤进行。
- 步骤包括根据SENTICOL-III试验识别盆腔前哨淋巴结,以及双侧韧带和血管离断、宫旁切除等。
- 术前近距离放疗在法国经验丰富的中心报告了良好的组织学反应,病理完全缓解率接近70%,尤其适用于肿瘤大小2-4cm或存在淋巴血管浸润者。
关键数值与推荐
- 推荐经阴道途径在无气腹下行阴道切开。
- 必须严格避免使用举宫器。
- 彻底机器人辅助阴道残端缝合,比较研究提示腹部缝合可能减少阴道并发症和裂开。
临床怎么用
- 对于早期宫颈癌需行根治性子宫切除术者,应告知微创手术与开腹手术的生存数据差异及风险获益比。
- 若选择微创路径,应在经验丰富的中心进行,并遵循标准化步骤,包括阴道途径阴道切开和避免举宫器。
- 术前近距离放疗可作为特定患者(肿瘤2-4cm或淋巴血管浸润)的选择,以期达到高病理完全缓解率。
局限性
- 本文为手术视频演示,非对照研究,不能提供疗效或安全性比较数据。
- 目前尚无国际推荐的根治性子宫切除术式,微创手术的安全性问题来自随机试验和大型回顾性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: Minimally invasive surgery decreases postoperative morbidity after radical hysterectomy (RH) for early-stage cervical cancer. However, a randomized trial and large retrospective data question its safety after observing lower rates of survival than open surgery [1,2]. The causes of this higher recurrence rate are not definitely established but may result from cancer exposure to the peritoneum during vaginal section and cancerous cells' spillage enhanced by pneumoperitoneum or a uterine manipulator. The aim of this surgical video was to present a standardized step-by-step approach for robotic RH according to the recent recommendations from the ARCAGY -Group of National Investigators for the Study of Ovarian and Breast Cancers surgeon's group [3]. DESIGN: Step-by-step video demonstration of the technique. SETTING: Tertiary center specialized in gynecologic oncology and minimally invasive surgery. INTERVENTIONS: A 48-year-old woman was diagnosed with a stage IB2 endocervical adenocarcinoma (International Federation of Gynecology and Obstetrics 2018) with a tumor size of 27 mm. Surgery was planned after preoperative pulsed dose rate uterovaginal brachytherapy. Surgery was performed following 10 reproducible steps: • Pelvic sentinel node identification according to the SENTICOL-III trial • Right infundibulopelvic and round ligaments transection • Right uterine vessels transection • Parametrectomy • Right uterosacral ligament transection • Bladder mobilization • Identical left dissection • Rectovaginal space development • Colpectomy by vaginal route after complete pneumoperitoneum exsufflation • Robotic vaginal cuff closure and pelvic inspection Thorough robotically assisted vaginal cuff closure was carried out as a comparative study suggesting that abdominal closure may decrease vaginal complications and dehiscence [3]. CONCLUSION: No international recommendations for the RH approach have yet been endorsed. Patients must be clearly informed about the benefit-risk ratio of the surgical route. If a minimally invasive RH is still decided, the patient should be referred to experienced centers, and precautionary measures must be implemented [4]. Colpotomy by vaginal route without pneumoperitoneum is recommended. Uterine manipulators have to be strictly avoided. Preoperative brachytherapy has been reported in experienced centers in France with favorable histologic response with high rates of pathologic complete response (near 70%) and seems particularly worthwhile for tumor sizes ranging from 2 to 4 cm or presenting with lymphovascular invasion [5].
引用
- Colombo PE, Nguyen VH, Taoum C, et al. Robotic Radical Hysterectomy for Cervical Adenocarcinoma after Preoperative Brachytherapy in 10 Steps. J Minim Invasive Gynecol. 2020. PMID: 33031927. doi:10.1016/j.jmig.2020.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。